NIH #U01CA256780
Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
- Amount
- $600K–$700K
- Period
- 2021-06-01 → 2026-05-31
- PIs
- 3
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
Jianjun Zhang
Full Professor(heuristic)
Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index67
i10-index225
Publications1,042
Citations21,016
Grants
5 total · 0 active
NIH #U01CA239522
Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer
- Amount
- $600K–$700K
- Period
- 2021-04-01 → 2026-03-31
- PIs
- 2
Awarded at INDIANA UNIVERSITY INDIANAPOLIS
NIH #R01CA234629
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma
- Amount
- $300K–$400K
- Period
- 2019-02-01 → 2024-01-31
- PIs
- 1
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Unbiased avidity-based isolation of antigen-specific T cells (Journal for ImmunoTherapy of Cancer)2026-07-01
- New preprint: CT-Based Deep Foundation Model for Predicting Immune Checkpoint Inhibitor-Induced Pneumonitis Risk in Lung Cancer2026-04-23
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-04
Data may not be current
Find elsewhere
ORCID: 0000-0001-7872-3477